Armstrong Henry H Associates Inc. Has $50.86 Million Stock Holdings in Procter & Gamble Company (The) $PG

Armstrong Henry H Associates Inc. lessened its position in Procter & Gamble Company (The) (NYSE:PG) by 3.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 354,872 shares of the company’s stock after selling 12,018 shares during the period. Procter & Gamble comprises about 4.7% of Armstrong Henry H Associates Inc.’s portfolio, making the stock its 5th largest holding. Armstrong Henry H Associates Inc.’s holdings in Procter & Gamble were worth $50,857,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Halbert Hargrove Global Advisors LLC acquired a new stake in Procter & Gamble in the third quarter valued at about $25,000. Saranac Partners Ltd bought a new position in shares of Procter & Gamble in the 3rd quarter worth $30,000. Corundum Trust Company INC purchased a new position in shares of Procter & Gamble during the third quarter valued at approximately $32,000. Caitlin John LLC bought a new position in shares of Procter & Gamble in the third quarter valued at approximately $34,000. Finally, Marquette Asset Management LLC purchased a new stake in Procter & Gamble in the 3rd quarter worth about $37,000. Institutional investors own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,827 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total value of $2,056,296.37. Following the completion of the sale, the insider owned 12,639 shares of the company’s stock, valued at approximately $2,026,158.09. This represents a 50.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the stock in a transaction on Friday, February 13th. The stock was sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the transaction, the insider owned 44,735 shares of the company’s stock, valued at $7,259,595.80. The trade was a 25.32% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 348,618 shares of company stock worth $55,462,643 over the last ninety days. 0.20% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have issued reports on PG shares. Dbs Bank raised Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Piper Sandler initiated coverage on shares of Procter & Gamble in a research note on Wednesday, January 7th. They issued a “neutral” rating and a $150.00 price target on the stock. UBS Group boosted their target price on shares of Procter & Gamble from $161.00 to $170.00 and gave the company a “buy” rating in a research note on Friday, January 23rd. JPMorgan Chase & Co. upgraded shares of Procter & Gamble from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $157.00 to $165.00 in a report on Friday, January 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on shares of Procter & Gamble from $176.00 to $171.00 and set a “buy” rating for the company in a research report on Monday, December 8th. Fourteen investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus price target of $168.33.

Procter & Gamble Stock Down 0.3%

Shares of Procter & Gamble stock opened at $144.41 on Friday. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $174.80. The company has a market capitalization of $335.61 billion, a P/E ratio of 21.39, a PEG ratio of 4.84 and a beta of 0.37. The business’s fifty day moving average price is $154.07 and its two-hundred day moving average price is $150.73. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, January 23rd. The company reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.86 by $0.02. The firm had revenue of $22.21 billion for the quarter, compared to the consensus estimate of $22.36 billion. Procter & Gamble had a return on equity of 32.21% and a net margin of 19.30%.The business’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.88 EPS. As a group, research analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd were issued a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. Procter & Gamble’s dividend payout ratio (DPR) is presently 62.67%.

Procter & Gamble Company Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.